Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EPH Receptor B2 anticorps (AA 17-200)

EPHB2 Reactivité: Humain ELISA, ICC Hôte: Souris Monoclonal 2D12C6 unconjugated
N° du produit ABIN1724695
  • Antigène Voir toutes EPH Receptor B2 (EPHB2) Anticorps
    EPH Receptor B2 (EPHB2)
    Épitope
    • 8
    • 8
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 17-200
    Reactivité
    • 59
    • 30
    • 13
    • 6
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 47
    • 15
    • 5
    • 2
    Souris
    Clonalité
    • 49
    • 20
    Monoclonal
    Conjugué
    • 40
    • 6
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp EPH Receptor B2 est non-conjugé
    Application
    • 48
    • 45
    • 25
    • 15
    • 11
    • 11
    • 8
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    ELISA, Immunocytochemistry (ICC)
    Fonction
    EphB2 Antibody
    Purification
    Ascitic fluid
    Immunogène
    Purified recombinant fragment of EphB2 (aa17-200) expressed in E. Coli.
    Clone
    2D12C6
    Isotype
    IgG2b
    Top Product
    Discover our top product EPHB2 Anticorps primaire
  • Indications d'application

    ELISA: 1/10000

    ICC: 1/200 - 1/1000

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Diehl, Bruno, Wilkinson, Loose, Wilting, Schweigerer, Klein: "Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations." dans: Pediatric research, Vol. 57, Issue 4, pp. 537-44, (2005) (PubMed).

    Huusko, Ponciano-Jackson, Wolf, Kiefer, Azorsa, Tuzmen, Weaver, Robbins, Moses, Allinen, Hautaniemi, Chen, Elkahloun, Basik, Bova, Bubendorf, Lugli, Sauter, Schleutker, Ozcelik, Elowe, Pawson, Trent et al.: "Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. ..." dans: Nature genetics, Vol. 36, Issue 9, pp. 979-83, (2004) (PubMed).

  • Antigène
    EPH Receptor B2 (EPHB2)
    Autre désignation
    EphB2 (EPHB2 Produits)
    Sujet

    Description: EphB2: EPH receptor B2. Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene is a receptor for ephrin-B family members.

    Aliases: DRT, ERK, CAPB, Hek5

    ID gène
    2048
    HGNC
    2048
    UniProt
    P29323
    Pathways
    Signalisation RTK, Regulation of long-term Neuronal Synaptic Plasticity, S100 Proteins
Vous êtes ici:
Support technique